Lyophilisation, or freeze-drying, is used to remove water, increase the stability of drug products and simplify transport and storage. It’s a technique that can be used for:
Lyophilisation is incredibly effective for supporting your product’s stability. But the necessary development timelines to integrate this into your process can take several months, so it must be planned out in advance.
At Symbiosis, we have vast experience in integrating lyophilisation services as part of aseptic filling within our GMP facility for small molecules and biopharmaceuticals, such as monoclonal antibodies (mAbs).
Over the years, we’ve encountered and overcome a range of technical lyophilisation challenges, so it’s rare that we come up against something unexpected. We also benefit from an extensive and trusted network of partners with dedicated lyophilisation specialisms that we can call upon for support.
We have two fully independent Tofflon lyophilisers housed in separate GMP manufacturing suites, accommodating cycles up to and beyond 72 hours, and dispersing up to 100 litres of bulk product per batch.
Whether you’ve already fully developed your lyophilisation cycle, or need our expert team to assist with the development and optimisation of the cycle, we’re here to help.
We’ve even designed a handy infographic that gives an overview of our approach to lyophilisation.
Want to be the first to know about our latest capabilities and offerings? Subscribe for Exclusive Updates
